Cartesian Therapeutics, Inc. (RNAC)
8.03
+0.17
(+2.16%)
USD |
NASDAQ |
Sep 18, 16:00
8.11
+0.08
(+1.00%)
After-Hours: 20:00
Cartesian Therapeutics Market Cap : 241.21M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 241.21M |
| September 17, 2026 | 236.10M |
| September 16, 2026 | 237.60M |
| September 15, 2026 | 237.00M |
| September 14, 2026 | 241.51M |
| September 11, 2026 | 246.01M |
| September 10, 2026 | 253.22M |
| September 09, 2026 | 261.03M |
| September 08, 2026 | 268.84M |
| September 04, 2026 | 278.45M |
| September 03, 2026 | 273.95M |
| September 02, 2026 | 272.74M |
| September 01, 2026 | 279.35M |
| August 31, 2026 | 278.75M |
| August 28, 2026 | 288.36M |
| August 27, 2026 | 299.48M |
| August 26, 2026 | 306.09M |
| August 25, 2026 | 311.79M |
| August 24, 2026 | 302.18M |
| August 21, 2026 | 301.58M |
| August 20, 2026 | 307.29M |
| August 19, 2026 | 315.10M |
| August 18, 2026 | 276.35M |
| August 17, 2026 | 275.75M |
| August 14, 2026 | 265.54M |
| Date | Value |
|---|---|
| August 13, 2026 | 261.93M |
| August 12, 2026 | 260.58M |
| August 11, 2026 | 257.88M |
| August 10, 2026 | 263.13M |
| August 07, 2026 | 265.84M |
| August 06, 2026 | 263.13M |
| August 05, 2026 | 250.82M |
| August 04, 2026 | 242.11M |
| August 03, 2026 | 236.40M |
| July 31, 2026 | 222.65M |
| July 30, 2026 | 220.65M |
| July 29, 2026 | 211.80M |
| July 28, 2026 | 218.37M |
| July 27, 2026 | 222.36M |
| July 24, 2026 | 224.93M |
| July 23, 2026 | 226.07M |
| July 22, 2026 | 232.07M |
| July 21, 2026 | 232.07M |
| July 20, 2026 | 233.50M |
| July 17, 2026 | 235.78M |
| July 16, 2026 | 237.78M |
| July 15, 2026 | 247.77M |
| July 14, 2026 | 246.06M |
| July 13, 2026 | 246.34M |
| July 10, 2026 | 270.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Allogene Therapeutics, Inc. | 583.63M |
| Beam Therapeutics, Inc. | 2.576B |
| Kyverna Therapeutics, Inc. | 439.00M |
| Arrowhead Pharmaceuticals, Inc. | 9.383B |
| Oncolytics Biotech, Inc. | 95.97M |
Market Cap Related Metrics
| PS Ratio | 147.78 |
| PEG Ratio | -0.0017 |
| Price | 8.03 |
| Earnings Yield | -73.96% |
| PEGY Ratio | -0.0017 |